Interims posted strong growth, helped by strong export sales and the acquisition of ARP, which is performing ahead of expectations. Organic growth of 8% was creditable given the declining market backdrop, with market shares also gained from new product development and high service standards. The Board is confident of achieving full-year expectations and we maintain our existing forecasts. We keep our target price at 410p, with upside scope over the next few years from accretive acquisition oppor ....
